FHIR Cross-Version Extensions package for FHIR R4B from FHIR R4 - Version 0.0.1-snapshot-2. See the Directory of published versions
| Official URL: http://hl7.org/fhir/4.0/ValueSet/R4-v2-0292-for-R4B | Version: 0.0.1-snapshot-2 | |||
| Standards status: Informative | Maturity Level: 0 | Computable Name: R4_v2_0292_for_R4B | ||
| This cross-version ValueSet represents concepts from http://terminology.hl7.org/ValueSet/v2-0292 | 2.9 for use in FHIR R4B. Concepts not present here have direct equivalent mappings crossing all versions from R4 to R4B. |
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
http://terminology.hl7.org/CodeSystem/v2-0292 version 2.9| Code | Display |
| 01 | DTP |
| 02 | OPV |
| 03 | MMR |
| 04 | M/R |
| 05 | measles |
| 06 | rubella |
| 07 | mumps |
| 08 | Hep B, adolescent or pediatric |
| 09 | Td (adult) |
| 10 | IPV |
| 100 | pneumococcal conjugate |
| 101 | typhoid, ViCPs |
| 102 | DTP-Hib-Hep B |
| 103 | meningococcal C conjugate |
| 104 | Hep A-Hep B |
| 105 | vaccinia (smallpox) diluted |
| 106 | DTaP, 5 pertussis antigens6 |
| 107 | DTaP, NOS |
| 108 | meningococcal, NOS |
| 109 | pneumococcal, NOS |
| 11 | pertussis |
| 110 | DTaP-Hep B-IPV |
| 111 | influenza, live, intranasal |
| 112 | tetanus toxoid, NOS |
| 113 | Td (adult) |
| 114 | meningococcal A,C,Y,W-135 diphtheria conjugate |
| 115 | Tdap |
| 116 | rotavirus, pentavalent |
| 117 | VZIG (IND) |
| 118 | HPV, bivalent |
| 119 | rotavirus, monovalent |
| 12 | diphtheria antitoxin |
| 120 | DTaP-Hib-IPV |
| 121 | zoster |
| 122 | rotavirus, NOS1 |
| 13 | TIG |
| 14 | IG, NOS |
| 15 | influenza, split (incl. purified surface antigen) |
| 16 | influenza, whole |
| 17 | Hib, NOS |
| 18 | rabies, intramuscular injection |
| 19 | BCG |
| 20 | DTaP |
| 21 | varicella |
| 22 | DTP-Hib |
| 23 | plague |
| 24 | anthrax |
| 25 | typhoid, oral |
| 26 | cholera |
| 27 | botulinum antitoxin |
| 28 | DT (pediatric) |
| 29 | CMVIG |
| 30 | HBIG |
| 31 | Hep A, pediatric, NOS |
| 32 | meningococcal |
| 33 | pneumococcal |
| 34 | RIG |
| 35 | tetanus toxoid |
| 36 | VZIG |
| 37 | yellow fever |
| 38 | rubella/mumps |
| 39 | Japanese encephalitis |
| 40 | rabies, intradermal injection |
| 41 | typhoid, parenteral |
| 42 | Hep B, adolescent/high risk infant2 |
| 43 | Hep B, adult4 |
| 44 | Hep B, dialysis |
| 45 | Hep B, NOS |
| 46 | Hib (PRP-D) |
| 47 | Hib (HbOC) |
| 48 | Hib (PRP-T) |
| 49 | Hib (PRP-OMP) |
| 50 | DTaP-Hib |
| 51 | Hib-Hep B |
| 52 | Hep A, adult |
| 53 | typhoid, parenteral, AKD (U.S. military) |
| 54 | adenovirus, type 4 |
| 55 | adenovirus, type 7 |
| 56 | dengue fever |
| 57 | hantavirus |
| 58 | Hep C |
| 59 | Hep E |
| 60 | herpes simplex 2 |
| 61 | HIV |
| 62 | HPV, quadrivalent |
| 63 | Junin virus |
| 64 | leishmaniasis |
| 65 | leprosy |
| 66 | Lyme disease |
| 67 | malaria |
| 68 | melanoma |
| 69 | parainfluenza-3 |
| 70 | Q fever |
| 71 | RSV-IGIV |
| 72 | rheumatic fever |
| 73 | Rift Valley fever |
| 74 | rotavirus, tetravalent |
| 75 | vaccinia (smallpox) |
| 76 | Staphylococcus bacterio lysate |
| 77 | tick-borne encephalitis |
| 78 | tularemia vaccine |
| 79 | vaccinia immune globulin |
| 80 | VEE, live |
| 81 | VEE, inactivated |
| 82 | adenovirus, NOS1 |
| 83 | Hep A, ped/adol, 2 dose |
| 84 | Hep A, ped/adol, 3 dose |
| 85 | Hep A, NOS |
| 86 | IG |
| 87 | IGIV |
| 88 | influenza, NOS |
| 89 | polio, NOS |
| 90 | rabies, NOS |
| 91 | typhoid, NOS |
| 92 | VEE, NOS |
| 93 | RSV-MAb |
| 94 | MMRV |
| 95 | TST-OT tine test |
| 96 | TST-PPD intradermal |
| 97 | TST-PPD tine test |
| 98 | TST, NOS |
| 99 | RESERVED - do not use3 |
| 998 | no vaccine administered5 |
| 999 | unknown |
This value set expansion contains 124 concepts.
| Code | System | Display |
| 01 | http://terminology.hl7.org/CodeSystem/v2-0292 | DTP |
| 02 | http://terminology.hl7.org/CodeSystem/v2-0292 | OPV |
| 03 | http://terminology.hl7.org/CodeSystem/v2-0292 | MMR |
| 04 | http://terminology.hl7.org/CodeSystem/v2-0292 | M/R |
| 05 | http://terminology.hl7.org/CodeSystem/v2-0292 | measles |
| 06 | http://terminology.hl7.org/CodeSystem/v2-0292 | rubella |
| 07 | http://terminology.hl7.org/CodeSystem/v2-0292 | mumps |
| 08 | http://terminology.hl7.org/CodeSystem/v2-0292 | Hep B, adolescent or pediatric |
| 09 | http://terminology.hl7.org/CodeSystem/v2-0292 | Td (adult) |
| 10 | http://terminology.hl7.org/CodeSystem/v2-0292 | IPV |
| 100 | http://terminology.hl7.org/CodeSystem/v2-0292 | pneumococcal conjugate |
| 101 | http://terminology.hl7.org/CodeSystem/v2-0292 | typhoid, ViCPs |
| 102 | http://terminology.hl7.org/CodeSystem/v2-0292 | DTP-Hib-Hep B |
| 103 | http://terminology.hl7.org/CodeSystem/v2-0292 | meningococcal C conjugate |
| 104 | http://terminology.hl7.org/CodeSystem/v2-0292 | Hep A-Hep B |
| 105 | http://terminology.hl7.org/CodeSystem/v2-0292 | vaccinia (smallpox) diluted |
| 106 | http://terminology.hl7.org/CodeSystem/v2-0292 | DTaP, 5 pertussis antigens6 |
| 107 | http://terminology.hl7.org/CodeSystem/v2-0292 | DTaP, NOS |
| 108 | http://terminology.hl7.org/CodeSystem/v2-0292 | meningococcal, NOS |
| 109 | http://terminology.hl7.org/CodeSystem/v2-0292 | pneumococcal, NOS |
| 11 | http://terminology.hl7.org/CodeSystem/v2-0292 | pertussis |
| 110 | http://terminology.hl7.org/CodeSystem/v2-0292 | DTaP-Hep B-IPV |
| 111 | http://terminology.hl7.org/CodeSystem/v2-0292 | influenza, live, intranasal |
| 112 | http://terminology.hl7.org/CodeSystem/v2-0292 | tetanus toxoid, NOS |
| 113 | http://terminology.hl7.org/CodeSystem/v2-0292 | Td (adult) |
| 114 | http://terminology.hl7.org/CodeSystem/v2-0292 | meningococcal A,C,Y,W-135 diphtheria conjugate |
| 115 | http://terminology.hl7.org/CodeSystem/v2-0292 | Tdap |
| 116 | http://terminology.hl7.org/CodeSystem/v2-0292 | rotavirus, pentavalent |
| 117 | http://terminology.hl7.org/CodeSystem/v2-0292 | VZIG (IND) |
| 118 | http://terminology.hl7.org/CodeSystem/v2-0292 | HPV, bivalent |
| 119 | http://terminology.hl7.org/CodeSystem/v2-0292 | rotavirus, monovalent |
| 12 | http://terminology.hl7.org/CodeSystem/v2-0292 | diphtheria antitoxin |
| 120 | http://terminology.hl7.org/CodeSystem/v2-0292 | DTaP-Hib-IPV |
| 121 | http://terminology.hl7.org/CodeSystem/v2-0292 | zoster |
| 122 | http://terminology.hl7.org/CodeSystem/v2-0292 | rotavirus, NOS1 |
| 13 | http://terminology.hl7.org/CodeSystem/v2-0292 | TIG |
| 14 | http://terminology.hl7.org/CodeSystem/v2-0292 | IG, NOS |
| 15 | http://terminology.hl7.org/CodeSystem/v2-0292 | influenza, split (incl. purified surface antigen) |
| 16 | http://terminology.hl7.org/CodeSystem/v2-0292 | influenza, whole |
| 17 | http://terminology.hl7.org/CodeSystem/v2-0292 | Hib, NOS |
| 18 | http://terminology.hl7.org/CodeSystem/v2-0292 | rabies, intramuscular injection |
| 19 | http://terminology.hl7.org/CodeSystem/v2-0292 | BCG |
| 20 | http://terminology.hl7.org/CodeSystem/v2-0292 | DTaP |
| 21 | http://terminology.hl7.org/CodeSystem/v2-0292 | varicella |
| 22 | http://terminology.hl7.org/CodeSystem/v2-0292 | DTP-Hib |
| 23 | http://terminology.hl7.org/CodeSystem/v2-0292 | plague |
| 24 | http://terminology.hl7.org/CodeSystem/v2-0292 | anthrax |
| 25 | http://terminology.hl7.org/CodeSystem/v2-0292 | typhoid, oral |
| 26 | http://terminology.hl7.org/CodeSystem/v2-0292 | cholera |
| 27 | http://terminology.hl7.org/CodeSystem/v2-0292 | botulinum antitoxin |
| 28 | http://terminology.hl7.org/CodeSystem/v2-0292 | DT (pediatric) |
| 29 | http://terminology.hl7.org/CodeSystem/v2-0292 | CMVIG |
| 30 | http://terminology.hl7.org/CodeSystem/v2-0292 | HBIG |
| 31 | http://terminology.hl7.org/CodeSystem/v2-0292 | Hep A, pediatric, NOS |
| 32 | http://terminology.hl7.org/CodeSystem/v2-0292 | meningococcal |
| 33 | http://terminology.hl7.org/CodeSystem/v2-0292 | pneumococcal |
| 34 | http://terminology.hl7.org/CodeSystem/v2-0292 | RIG |
| 35 | http://terminology.hl7.org/CodeSystem/v2-0292 | tetanus toxoid |
| 36 | http://terminology.hl7.org/CodeSystem/v2-0292 | VZIG |
| 37 | http://terminology.hl7.org/CodeSystem/v2-0292 | yellow fever |
| 38 | http://terminology.hl7.org/CodeSystem/v2-0292 | rubella/mumps |
| 39 | http://terminology.hl7.org/CodeSystem/v2-0292 | Japanese encephalitis |
| 40 | http://terminology.hl7.org/CodeSystem/v2-0292 | rabies, intradermal injection |
| 41 | http://terminology.hl7.org/CodeSystem/v2-0292 | typhoid, parenteral |
| 42 | http://terminology.hl7.org/CodeSystem/v2-0292 | Hep B, adolescent/high risk infant2 |
| 43 | http://terminology.hl7.org/CodeSystem/v2-0292 | Hep B, adult4 |
| 44 | http://terminology.hl7.org/CodeSystem/v2-0292 | Hep B, dialysis |
| 45 | http://terminology.hl7.org/CodeSystem/v2-0292 | Hep B, NOS |
| 46 | http://terminology.hl7.org/CodeSystem/v2-0292 | Hib (PRP-D) |
| 47 | http://terminology.hl7.org/CodeSystem/v2-0292 | Hib (HbOC) |
| 48 | http://terminology.hl7.org/CodeSystem/v2-0292 | Hib (PRP-T) |
| 49 | http://terminology.hl7.org/CodeSystem/v2-0292 | Hib (PRP-OMP) |
| 50 | http://terminology.hl7.org/CodeSystem/v2-0292 | DTaP-Hib |
| 51 | http://terminology.hl7.org/CodeSystem/v2-0292 | Hib-Hep B |
| 52 | http://terminology.hl7.org/CodeSystem/v2-0292 | Hep A, adult |
| 53 | http://terminology.hl7.org/CodeSystem/v2-0292 | typhoid, parenteral, AKD (U.S. military) |
| 54 | http://terminology.hl7.org/CodeSystem/v2-0292 | adenovirus, type 4 |
| 55 | http://terminology.hl7.org/CodeSystem/v2-0292 | adenovirus, type 7 |
| 56 | http://terminology.hl7.org/CodeSystem/v2-0292 | dengue fever |
| 57 | http://terminology.hl7.org/CodeSystem/v2-0292 | hantavirus |
| 58 | http://terminology.hl7.org/CodeSystem/v2-0292 | Hep C |
| 59 | http://terminology.hl7.org/CodeSystem/v2-0292 | Hep E |
| 60 | http://terminology.hl7.org/CodeSystem/v2-0292 | herpes simplex 2 |
| 61 | http://terminology.hl7.org/CodeSystem/v2-0292 | HIV |
| 62 | http://terminology.hl7.org/CodeSystem/v2-0292 | HPV, quadrivalent |
| 63 | http://terminology.hl7.org/CodeSystem/v2-0292 | Junin virus |
| 64 | http://terminology.hl7.org/CodeSystem/v2-0292 | leishmaniasis |
| 65 | http://terminology.hl7.org/CodeSystem/v2-0292 | leprosy |
| 66 | http://terminology.hl7.org/CodeSystem/v2-0292 | Lyme disease |
| 67 | http://terminology.hl7.org/CodeSystem/v2-0292 | malaria |
| 68 | http://terminology.hl7.org/CodeSystem/v2-0292 | melanoma |
| 69 | http://terminology.hl7.org/CodeSystem/v2-0292 | parainfluenza-3 |
| 70 | http://terminology.hl7.org/CodeSystem/v2-0292 | Q fever |
| 71 | http://terminology.hl7.org/CodeSystem/v2-0292 | RSV-IGIV |
| 72 | http://terminology.hl7.org/CodeSystem/v2-0292 | rheumatic fever |
| 73 | http://terminology.hl7.org/CodeSystem/v2-0292 | Rift Valley fever |
| 74 | http://terminology.hl7.org/CodeSystem/v2-0292 | rotavirus, tetravalent |
| 75 | http://terminology.hl7.org/CodeSystem/v2-0292 | vaccinia (smallpox) |
| 76 | http://terminology.hl7.org/CodeSystem/v2-0292 | Staphylococcus bacterio lysate |
| 77 | http://terminology.hl7.org/CodeSystem/v2-0292 | tick-borne encephalitis |
| 78 | http://terminology.hl7.org/CodeSystem/v2-0292 | tularemia vaccine |
| 79 | http://terminology.hl7.org/CodeSystem/v2-0292 | vaccinia immune globulin |
| 80 | http://terminology.hl7.org/CodeSystem/v2-0292 | VEE, live |
| 81 | http://terminology.hl7.org/CodeSystem/v2-0292 | VEE, inactivated |
| 82 | http://terminology.hl7.org/CodeSystem/v2-0292 | adenovirus, NOS1 |
| 83 | http://terminology.hl7.org/CodeSystem/v2-0292 | Hep A, ped/adol, 2 dose |
| 84 | http://terminology.hl7.org/CodeSystem/v2-0292 | Hep A, ped/adol, 3 dose |
| 85 | http://terminology.hl7.org/CodeSystem/v2-0292 | Hep A, NOS |
| 86 | http://terminology.hl7.org/CodeSystem/v2-0292 | IG |
| 87 | http://terminology.hl7.org/CodeSystem/v2-0292 | IGIV |
| 88 | http://terminology.hl7.org/CodeSystem/v2-0292 | influenza, NOS |
| 89 | http://terminology.hl7.org/CodeSystem/v2-0292 | polio, NOS |
| 90 | http://terminology.hl7.org/CodeSystem/v2-0292 | rabies, NOS |
| 91 | http://terminology.hl7.org/CodeSystem/v2-0292 | typhoid, NOS |
| 92 | http://terminology.hl7.org/CodeSystem/v2-0292 | VEE, NOS |
| 93 | http://terminology.hl7.org/CodeSystem/v2-0292 | RSV-MAb |
| 94 | http://terminology.hl7.org/CodeSystem/v2-0292 | MMRV |
| 95 | http://terminology.hl7.org/CodeSystem/v2-0292 | TST-OT tine test |
| 96 | http://terminology.hl7.org/CodeSystem/v2-0292 | TST-PPD intradermal |
| 97 | http://terminology.hl7.org/CodeSystem/v2-0292 | TST-PPD tine test |
| 98 | http://terminology.hl7.org/CodeSystem/v2-0292 | TST, NOS |
| 99 | http://terminology.hl7.org/CodeSystem/v2-0292 | RESERVED - do not use3 |
| 998 | http://terminology.hl7.org/CodeSystem/v2-0292 | no vaccine administered5 |
| 999 | http://terminology.hl7.org/CodeSystem/v2-0292 | unknown |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |